Ventral hippocampal molecular pathways and impaired neurogenesis associated with 5-HT 1A and 5-HT 1B receptors disruption in mice

Neuroscience Letters

Volumn 521, Issue 1, 2012, Pages 20-25

  Xia, Lin ^a   Deloménie, Claudine ^b   David, Indira ^a   Rainer, Quentin ^a   Marouard, Myriam ^c   Delacroix, Hervé ^c   David, Denis J ^a   Gardier, Alain M ^a   Guilloux, Jean Philippe ^a  

^a University of Paris XI   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c CENTRE DE GÉNÉTIQUE MOLÉCULAIRE   (France)

Author keywords

5 HT 1A and 5 HT 1B receptors; Hippocampus; Microarray; Neurogenesis; Serotonin

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DERIVED NEUROTROPHIC FACTOR GENE; CAMK2A GENE; CAMK4 GENE; CELL PROLIFERATION; CELL SURVIVAL; DOWN REGULATION; GENE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; KLF9 GENE; MALE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTONIN 1A RECEPTOR GENE; SEROTONIN 1B RECEPTOR GENE;

ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION PROFILING; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, KNOCKOUT; NEUROGENESIS; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT1B;

EID: 84862619086     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.05.046     Document Type: Article

References (36)

1. Baldwin D.S., Waldman S., Allgulander C. Evidence-based pharmacological treatment of generalized anxiety disorder. International Journal of Neuropsychopharmacology 2011, 14:697-710.
2. Banasr M., Hery M., Printemps R., Daszuta A. Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone. Neuropsychopharmacology 2004, 29:450-460.
3. Bannerman D.M., Grubb M., Deacon R.M., Yee B.K., Feldon J., Rawlins J.N. Ventral hippocampal lesions affect anxiety but not spatial learning. Behavioural Brain Research 2003, 139:197-213.
4. Barr J.L., Forster G.L. Serotonergic neurotransmission in the ventral hippocampus is enhanced by corticosterone and altered by chronic amphetamine treatment. Neuroscience 2011, 182:105-114.
5. David D.J., Samuels B.A., Rainer Q., Wang J.W., Marsteller D., Mendez I., Drew M., Craig D.A., Guiard B.P., Guilloux J.P., Artymyshyn R.P., Gardier A.M., Gerald C., Antonijevic I.A., Leonardo E.D., Hen R. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 2009, 62:479-493.
6. Duff K., Paulsen J.S., Beglinger L.J., Langbehn D.R., Stout J.C. Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study. Biological Psychiatry 2007, 62:1341-1346.
7. Gage F.H., Thompson R.G. Differential distribution of norepinephrine and serotonin along the dorsal-ventral axis of the hippocampal formation. Brain Research Bulletin 1980, 5:771-773.
8. Gingrich J.A., Hen R. Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology 2001, 155:1-10.
9. Guiard B.P., David D.J., Deltheil T., Chenu F., Le Maitre E., Renoir T., Leroux-Nicollet I., Sokoloff P., Lanfumey L., Hamon M., Andrews A.M., Hen R., Gardier A.M. Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype. International Journal of Neuropsychopharmacology 2008, 11:79-92.
10. -/- mice: an animal model sensitive to anxiolytic treatments. Neuropharmacology 2011, 61:478-488.
11. Hunsberger J.G., Newton S.S., Bennett A.H., Duman C.H., Russell D.S., Salton S.R., Duman R.S. Antidepressant actions of the exercise-regulated gene VGF. Nature Medicine 2007, 13:1476-1482.
12. Jayatissa M.N., Bisgaard C., Tingstrom A., Papp M., Wiborg O. Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression. Neuropsychopharmacology 2006, 31:2395-2404.
13. Jha S., Rajendran R., Fernandes K.A., Vaidya V.A. 5-HT2A/2C receptor blockade regulates progenitor cell proliferation in the adult rat hippocampus. Neuroscience Letters 2008, 441:210-214.
14. Julien C.L., Thompson J.C., Wild S., Yardumian P., Snowden J.S., Turner G., Craufurd D. Psychiatric disorders in preclinical Huntington's disease. Journal of Neurology, Neurosurgery and Psychiatry 2007, 78:939-943.
15. Klempin F., Babu H., De Pietri Tonelli D., Alarcon E., Fabel K., Kempermann G. Oppositional effects of serotonin receptors 5-HT1a, 2, and 2c in the regulation of adult hippocampal neurogenesis. Frontiers in Molecular Neuroscience 2010, 3.
16. Kulak A., Cuenod M., Do K.Q. Behavioral phenotyping of glutathione-deficient mice: relevance to schizophrenia and bipolar disorder. Behavioural Brain Research 2012, 226:563-570.
17. Leonardo E.D., Richardson-Jones J.W., Sibille E., Kottman A., Hen R. Molecular heterogeneity along the dorsal-ventral axis of the murine hippocampal CA1 field: a microarray analysis of gene expression. Neuroscience 2006, 137:177-186.
18. Lyons W.E., Mamounas L.A., Ricaurte G.A., Coppola V., Reid S.W., Bora S.H., Wihler C., Koliatsos V.E., Tessarollo L. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:15239-15244.
19. Menalled L., El-Khodor B.F., Patry M., Suarez-Farinas M., Orenstein S.J., Zahasky B., Leahy C., Wheeler V., Yang X.W., MacDonald M., Morton A.J., Bates G., Leeds J., Park L., Howland D., Signer E., Tobin A., Brunner D. Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models. Neurobiology of Disease 2009, 35:319-336.
20. O'Donnell P., Grace A.A. Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input. Journal of Neuroscience 1995, 15:3622-3639.
21. Parks C.L., Robinson P.S., Sibille E., Shenk T., Toth M. Increased anxiety of mice lacking the serotonin1A receptor. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:10734-10739.
22. Pitkanen A., Pikkarainen M., Nurminen N., Ylinen A. Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex, and postrhinal cortex in rat. A review. Annals of the New York Academy of Sciences 2000, 911:369-391.
23. Radley J.J., Jacobs B.L. 5-HT1A receptor antagonist administration decreases cell proliferation in the dentate gyrus. Brain Research 2002, 955:264-267.
24. Rainer Q., Xia L., Guilloux J.P., Gabriel C., Mocaer E., Hen R., Enhamre E., Gardier A.M., David D.J. Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety. International Journal of Neuropsychopharmacology 2011, 1-15.
25. Rex A., Voigt J.P., Fink H. Anxiety but not arousal increases 5-hydroxytryptamine release in the rat ventral hippocampus in vivo. European Journal of Neuroscience 2005, 22:1185-1189.
26. Rios M., Fan G., Fekete C., Kelly J., Bates B., Kuehn R., Lechan R.M., Jaenisch R. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Molecular Endocrinology 2001, 15:1748-1757.
27. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
28. Saudou F., Amara D.A., Dierich A., LeMeur M., Ramboz S., Segu L., Buhot M.C., Hen R. Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 1994, 265:1875-1878.
29. Scharfman H., Goodman J., Macleod A., Phani S., Antonelli C., Croll S. Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats. Experimental Neurology 2005, 192:348-356.
30. Scobie K.N., Hall B.J., Wilke S.A., Klemenhagen K.C., Fujii-Kuriyama Y., Ghosh A., Hen R., Sahay A. Kruppel-like factor 9 is necessary for late-phase neuronal maturation in the developing dentate gyrus and during adult hippocampal neurogenesis. Journal of Neuroscience 2009, 29:9875-9887.
31. Sillaber I., Panhuysen M., Henniger M.S., Ohl F., Kuhne C., Putz B., Pohl T., Deussing J.M., Paez-Pereda M., Holsboer F. Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine. Psychopharmacology 2008, 200:557-572.
32. Soumier A., Banasr M., Goff L.K., Daszuta A. Region- and phase-dependent effects of 5-HT(1A) and 5-HT(2C) receptor activation on adult neurogenesis. European Neuropsychopharmacology 2010, 20:336-345.
33. Surget A., Wang Y., Leman S., Ibarguen-Vargas Y., Edgar N., Griebel G., Belzung C., Sibille E. Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal. Neuropsychopharmacology 2009, 34:1363-1380.
34. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 2002, 3. RESEARCH0034.
35. Verwer R.W., Meijer R.J., Van Uum H.F., Witter M.P. Collateral projections from the rat hippocampal formation to the lateral and medial prefrontal cortex. Hippocampus 1997, 7:397-402.
36. Zhang Q., Liu G., Wu Y., Sha H., Zhang P., Jia J. BDNF promotes EGF-induced proliferation and migration of human fetal neural stem/progenitor cells via the PI3K/Akt pathway. Molecules 2011, 16:10146-10156.